Skip to Content

GV21-02

Main Content

Determinants of successful discontinuation of immune suppression following allogeneic hematopoietic cell transplantation: A validation study.

Study #: GV21-02

Study Status: Analysis

Presentation(s)

2025, Tandem (Oral)